Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 01, 2022

SELL
$57.25 - $86.63 $234,324 - $354,576
-4,093 Closed
0 $0
Q1 2022

May 10, 2022

SELL
$71.02 - $86.99 $5,113 - $6,263
-72 Reduced 1.73%
4,093 $335,000
Q4 2021

Feb 08, 2022

BUY
$76.72 - $92.68 $17,799 - $21,501
232 Added 5.9%
4,165 $364,000
Q3 2021

Nov 12, 2021

SELL
$76.02 - $88.62 $18,320 - $21,357
-241 Reduced 5.77%
3,933 $311,000
Q2 2021

Aug 12, 2021

BUY
$73.44 - $87.01 $5,067 - $6,003
69 Added 1.68%
4,174 $351,000
Q1 2021

May 14, 2021

BUY
$62.9 - $82.41 $258,204 - $338,293
4,105 New
4,105 $303,000
Q1 2020

May 15, 2020

SELL
$34.22 - $76.49 $182,221 - $407,309
-5,325 Closed
0 $0
Q4 2019

Feb 18, 2020

BUY
$68.92 - $85.27 $20,882 - $25,836
303 Added 6.03%
5,325 $402,000
Q3 2019

Nov 12, 2019

SELL
$71.74 - $86.35 $78,124 - $94,035
-1,089 Reduced 17.82%
5,022 $371,000
Q2 2019

Aug 13, 2019

SELL
$66.45 - $97.36 $28,772 - $42,156
-433 Reduced 6.62%
6,111 $440,000
Q1 2019

May 15, 2019

BUY
$86.15 - $100.49 $131,292 - $153,146
1,524 Added 30.36%
6,544 $636,000
Q4 2018

Feb 14, 2019

SELL
$84.14 - $125.42 $245,436 - $365,850
-2,917 Reduced 36.75%
5,020 $459,000
Q3 2018

Nov 13, 2018

BUY
$101.02 - $130.95 $119,405 - $154,782
1,182 Added 17.5%
7,937 $984,000
Q2 2018

Aug 13, 2018

SELL
$81.75 - $105.37 $38,504 - $49,629
-471 Reduced 6.52%
6,755 $674,000
Q1 2018

May 14, 2018

BUY
$79.95 - $89.74 $76,112 - $85,432
952 Added 15.17%
7,226 $640,000
Q4 2017

Feb 14, 2018

BUY
$71.8 - $88.21 $39,274 - $48,250
547 Added 9.55%
6,274 $501,000
Q3 2017

Nov 13, 2017

BUY
$60.32 - $70.06 $4,463 - $5,184
74 Added 1.31%
5,727 $401,000
Q2 2017

Aug 11, 2017

BUY
N/A
5,653
5,653 $346,000

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.79B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.